Older adults who received at least one flu vaccination were 40% less likely to develop Alzheimer's disease over the course of a four year follow up than their peers who did not receive a vaccine.
Multiple sclerosis patients who take Rituximab have a better response to the COVID-19 vaccine if they have a higher B cell count.
Vaccine hesitance waned over time, and the majority of caregivers and dependents with ASD received the COVID-19 vaccine following FDA approval. However, overall vaccine hesitancy influenced COVID-19 vaccine uptake in a minority of caregivers and dependents with ASD. Recent findings reveal that those on the autism spectrum are at greater risk of hospitalization following COVID-19 infection, and historically, a significant portion of parents of children with ASD are more likely to delay or decline any childhood vaccines.
90 minutes of mild-to-moderate intensity exercise directly following a vaccine for the flu or COVID may help provide an extra immune boost.
A newly developed antibody-based treatment and protein-based vaccine reduced Alzheimer's symptoms in mouse models, researchers report.
A new protein-based vaccine shows promise for improving bone quality and preventing rheumatoid arthritis.
Researchers report a cleaner living environment may not detrimentally impact a child's developing immune system, as current theories suggest.
Narratives and storytelling can help counter vaccine misinformation as the method can create a bridge between scientific evidence and human experience.
A number of videos have surfaced on popular channels showing people experiencing some adverse effects following the coronavirus vaccine. Researchers say some of the cases could be related to functional neurological disorder, a common neuropsychological condition.
Researchers have carried out clinical trials to test a mutation-specific vaccine against malignant brain tumors. The vaccine has been found to be safe and effective in triggering the desired immune response in the brain cancer tumors.
When injected with the new mRNA vaccine, mice with multiple sclerosis-like symptoms developed less severe symptoms than would normally occur.
A newly developed experimental vaccine can diminish the fatal respiratory effects of carfentanil and fentanyl in rodent models.
